Relation of Albuminuria to Left Ventricular Mass (from the HyperGEN Study)

American Journal of Cardiology

Volumn 101, Issue 2, 2008, Pages 212-216

  Djoussé, Luc ^a,b   Kochar, Jinesh ^a   Hunt, Steven C ^c   North, Kari E ^d   Gu, C Charles ^e   Tang, Weihong ^f   Arnett, Donna K ^g   Devereux, Richard B ^h  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d The University of North Carolina at Chapel Hill   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; ECHOCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREVALENCE; UNITED STATES; URINALYSIS;

EID: 37549048217     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.07.065     Document Type: Article

References (25)

1. Tsioufis C., Stefanadis C., Toutouza M., Kallikazaros I., Toutouzas K., Tousoulis D., Pitsavos C., Papademetriou V., and Toutouzas P. Microalbuminuria is associated with unfavourable cardiac geometric adaptations in essential hypertensive subjects. J Hum Hypertens 16 (2002) 249-254
2. Olsen M.H., Wachtell K., Borch-Johnsen K., Okin P.M., Kjeldsen S.E., Dahlof B., Devereux R.B., and Ibsen H. A blood pressure independent association between glomerular albumin leakage and electrocardiographic left ventricular hypertrophy. The LIFE Study. Losartan Intervention For Endpoint reduction. J Hum Hypertens 16 (2002) 591-595
3. Williams R.R., Rao D.C., Ellison R.C., Arnett D.K., Heiss G., Oberman A., Eckfeldt J.H., Leppert M.F., Province M.A., Mockrin S.C., and Hunt S.C. NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension Genetic Epidemiology Network. Ann Epidemiol 10 (2000) 389-400
4. Palmieri V., Bella J.N., Arnett D.K., Liu J.E., Oberman A., Schuck M.Y., Kitzman D.W., Hopkins P.N., Morgan D., Rao D.C., and Devereux R.B. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation 103 (2001) 102-107
5. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
6. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., and Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
7. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., and Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
8. Fesler P., Du C.G., Ribstein J., and Mimran A. Heterogeneity of cardiorenal characteristics in normotensive subjects. Hypertension 43 (2004) 219-223
9. Picca M., Agozzino F., and Pelosi G. Influence of microalbuminuria on left ventricular geometry and function in hypertensive patients with type 2 diabetes mellitus. Ital Heart J 4 (2003) 48-52
10. Ratto E., Leoncini G., Viazzi F., Vaccaro V., Parodi A., Falqui V., Bezante G.P., Tomolillo C., Deferrari G., and Pontremoli R. Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised?. Am J Hypertens 19 (2006) 728-734
11. Pedrinelli R., Bello V.D., Catapano G., Talarico L., Materazzi F., Santoro G., Giusti C., Mosca F., Melillo E., and Ferrari M. Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. Arterioscler Thromb 13 (1993) 900-906
12. Gatzka C.D., Reid C.M., Lux A., Dart A.M., and Jennings G.L. Left ventricular mass and microalbuminuria: relation to ambulatory blood pressure. Hypertension Diagnostic Service Investigators. Clin Exp Pharmacol Physiol 26 (1999) 514-516
13. Wachtell K., Palmieri V., Olsen M.H., Bella J.N., Aalto T., Dahlof B., Gerdts E., Wright Jr. J.T., Papademetriou V., Mogensen C.E., et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 143 (2002) 319-326
14. Dell'omo G., Giorgi D., Di B., V, Mariani M., and Pedrinelli R. Blood pressure independent association of microalbuminuria and left ventricular hypertrophy in hypertensive men. J Intern Med 254 (2003) 76-84
15. Pontremoli R., Ravera M., Bezante G.P., Viazzi F., Nicolella C., Berruti V., Leoncini G., Del Sette M., Brunelli C., Tomolillo C., and Deferrari G. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 17 (1999) 993-1000
16. Redon J., Baldo E., Lurbe E., Bertolin V., Lozano J.V., Miralles A., and Pascual J.M. Microalbuminuria, left ventricular mass and ambulatory blood pressure in essential hypertension. Kidney Int 55 suppl (1996) S81-S84
17. Arnlov J., Evans J.C., Meigs J.B., Wang T.J., Fox C.S., Levy D., Benjamin E.J., D'Agostino R.B., and Vasan R.S. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112 (2005) 969-975
18. Martinez M.A., Sancho T., Armada E., Rubio J.M., Anton J.L., Torre A., Palau J., Seguido P., Gallo J., Saenz I., et al. Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification. Am J Hypertens 16 (2003) 556-563
19. Pascual J.M., Rodilla E., Gonzalez C., Perez-Hoyos S., and Redon J. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension 45 (2005) 1125-1130
20. Palatini P., Mormino P., Dorigatti F., Santonastaso M., Mos L., De Toni R., Winnicki M., Dal Follo M., Biasion T., Garavelli G., and Pessina A.C. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 70 (2006) 578-584
21. Redon J., and Pascual J.M. Development of microalbuminuria in essential hypertension. Curr Hypertens Rep 8 (2006) 171-177
22. Matsumura K., Fujii K., Oniki H., Oka M., and Iida M. Role of aldosterone in left ventricular hypertrophy in hypertension. Am J Hypertens 19 (2006) 13-18
23. Clausen P., Jensen J.S., Jensen G., Borch-Johnsen K., and Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 103 (2001) 1869-1874
24. Nakamura M., Onoda T., Itai K., Ohsawa M., Satou K., Sakai T., Segawa T., Sasaki J., Tonari Y., Hiramori K., and Okayama A. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med 43 (2004) 919-925
25. Jensen J.S. Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle-aged individuals. Clin Chim Acta 243 (1995) 95-99